Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders

Details for Australian Patent Application No. 2008252853 (hide)

Owner Ablynx N.V.

Inventors Beirnaert, Els; Hoogenboom, Hendricus Renerus Jacobus Matteus; Cornelis, Sigrid

Agent Shelston IP

Pub. Number AU-B-2008252853

PCT Pub. Number WO2008/142164

Priority 60/939,929 24.05.07 US; 61/024,256 29.01.08 US

Filing date 23 May 2008

Wipo publication date 27 November 2008

Acceptance publication date 1 December 2011

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 19/10 (2006.01) Drugs for skeletal disorders

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/142164 Priority application(s): WO2008/142164

1 December 2011 Application Accepted

  Published as AU-B-2008252853

29 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008252854-Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors

2008252852-Plants having enhanced yield-related traits and a method for making the same